Drugs / Autologous stromal vascular fraction cells
last change Dec 2016 re-read 3 minutes ago

Autologous stromal vascular fraction cells

Cell therapy

Developed for
rheumatoid arthritis
Investigated by
Translational Biosciences

Trials 1

20142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1/2 NCT01885819 Jun 2013 → Jul 2016 rheumatoid arthritis Translational Biosciences Withdrawn No outcome recorded Stop: Business

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Autologous stromal vascular fraction cells ClinicalTrials.gov intervention name — accepted as the source's own label NCT01885819 ↗
Modality Cell therapy “Autologous stromal vascular fraction cells” NCT01885819 ↗